Your browser doesn't support javascript.
loading
Cas9-Geminin and Cdt1-fused anti-CRISPR protein synergistically increase editing accuracy.
Matsumoto, Daisuke; Kishi, Kanae; Matsugi, Erina; Inoue, Yuto; Nigorikawa, Kiyomi; Nomura, Wataru.
Affiliation
  • Matsumoto D; Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
  • Kishi K; School of Pharmaceutical Sciences, Hiroshima University, Japan.
  • Matsugi E; Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
  • Inoue Y; Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
  • Nigorikawa K; School of Pharmaceutical Sciences, Hiroshima University, Japan.
  • Nomura W; Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
FEBS Lett ; 597(7): 985-994, 2023 04.
Article in En | MEDLINE | ID: mdl-36905332
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Limits: Humans Language: En Journal: FEBS Lett Year: 2023 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Limits: Humans Language: En Journal: FEBS Lett Year: 2023 Document type: Article Affiliation country: Japón